Clinical data | |
---|---|
Trade names | Dalmarelin, Ovucron, Reproreline |
Other names | H-Pyr-His-Trp-Ser-Tyr-D-Gly(tBu)-Leu-Arg-Pro-NHEt; XHWSYXLRP |
Routes of administration | Injection |
Drug class | GnRH agonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.224.787 |
Chemical and physical data | |
Formula | C59H84N16O12 |
Molar mass | 1209.421 g·mol−1 |
3D model (JSmol) | |
| |
|
Lecirelin, sold under the brand names Dalmarelin, Ovucron, and Reproreline, is a short-acting gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Israel.[1][2][3][4] It is a GnRH analogue and a synthetic peptide, specifically a nonapeptide.[1][2][3] The drug was introduced for veterinary use by 2000.[5] It is used in form of the acetate salt.[6]